Apolipoprotein E Genotype and Sex Influence Glucose Tolerance in Older Adults: A Cross-Sectional Study
- PMID: 27065114
- PMCID: PMC4821139
- DOI: 10.1159/000444079
Apolipoprotein E Genotype and Sex Influence Glucose Tolerance in Older Adults: A Cross-Sectional Study
Abstract
Background: Glucose intolerance and apolipoprotein ε4 allele (E4+) are risk factors for Alzheimer's disease (AD). Insulin sensitizers show promise for treating AD, but are less effective in E4+ individuals. Little is known about how the APOE genotype influences glucose metabolism.
Methods: Cross-sectional analysis of 319 older adults who underwent oral glucose tolerance tests; a subset had insulin, amyloid beta (Aβ42), and Mini Mental Status Examination. Glucose and insulin patterns with respect to cognitive diagnosis, E4 status, and sex were examined with analysis of covariance and Pearson correlation.
Results: People with cognitive impairment had higher fasting insulin levels. E4 status did not affect fasting glucose values, whereas men had higher fasting glucose levels than women. E4+ men had the lowest and E4+ women had the highest glucose levels, compared to E4- groups; insulin did not differ by sex or E4 group. E4 status and sex moderated correlations between metabolic measures and AD risk factors including age and Aβ.
Conclusions: Insulin resistance was associated with cognitive impairment, and sex, E4 status, and glucose values are interrelated in older adults at risk of AD. Understanding glucose metabolism for different APOE and sex groups may help elucidate differences in therapeutic responses.
Keywords: Alzheimer's disease; Apolipoprotein ε4 allele; Glucose intolerance; Oral glucose tolerance test.
Figures
Similar articles
-
Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.JAMA Psychiatry. 2014 Oct;71(10):1183-91. doi: 10.1001/jamapsychiatry.2014.1060. JAMA Psychiatry. 2014. PMID: 25162367
-
Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):515-7. doi: 10.1136/jnnp.2005.063917. J Neurol Neurosurg Psychiatry. 2006. PMID: 16543533 Free PMC article.
-
Differential Effects of Meal Challenges on Cognition, Metabolism, and Biomarkers for Apolipoprotein E ɛ4 Carriers and Adults with Mild Cognitive Impairment.J Alzheimers Dis. 2015;48(1):205-18. doi: 10.3233/JAD-150273. J Alzheimers Dis. 2015. PMID: 26401941
-
Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study.BMJ. 1997 Oct 25;315(7115):1045-9. doi: 10.1136/bmj.315.7115.1045. BMJ. 1997. PMID: 9366728 Free PMC article.
-
Effect of Apolipoprotein E ɛ4 Carrier Status on Cognitive Response to Acetylcholinesterase Inhibitors in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis.Dement Geriatr Cogn Disord. 2018;45(5-6):335-352. doi: 10.1159/000490175. Epub 2018 Jul 24. Dement Geriatr Cogn Disord. 2018. PMID: 30041236
Cited by
-
APOE Genotype Influences Postprandial Blood Pressure after High Fat Feeding in Older Adults.J Nutr Health Aging. 2019;23(5):408-413. doi: 10.1007/s12603-019-1167-0. J Nutr Health Aging. 2019. PMID: 31021357 Free PMC article.
-
APOE genotype affects metabolic and Alzheimer-related outcomes induced by Western diet in female EFAD mice.FASEB J. 2019 Mar;33(3):4054-4066. doi: 10.1096/fj.201801756R. Epub 2018 Dec 3. FASEB J. 2019. PMID: 30509127 Free PMC article.
-
Apolipoprotein E4 mediates insulin resistance-associated cerebrovascular dysfunction and the post-prandial response.J Cereb Blood Flow Metab. 2019 May;39(5):770-781. doi: 10.1177/0271678X17746186. Epub 2017 Dec 7. J Cereb Blood Flow Metab. 2019. PMID: 29215310 Free PMC article.
-
ApoE and cerebral insulin: Trafficking, receptors, and resistance.Neurobiol Dis. 2020 Apr;137:104755. doi: 10.1016/j.nbd.2020.104755. Epub 2020 Jan 21. Neurobiol Dis. 2020. PMID: 31978603 Free PMC article. Review.
-
Multiple Mechanisms Linking Type 2 Diabetes and Alzheimer's Disease: Testosterone as a Modifier.J Alzheimers Dis. 2017;59(2):445-466. doi: 10.3233/JAD-161259. J Alzheimers Dis. 2017. PMID: 28655134 Free PMC article. Review.
References
-
- Cholerton B, Baker LD, Craft S. Insulin resistance and pathological brain ageing. Diabet Med. 2011;28:1463–1475. - PubMed
-
- Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A, Fuino RL, Kawaguchi KR, Samoyedny AJ, Wilson RS, Arvanitakis Z, Schneider JA, Wolf BA, Bennett DA, Trojanowski JQ, Arnold SE. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest. 2012;122:1316–1338. - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous